Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 10 July 2008, doi:10.1136/bmj.a337
Cite this as: BMJ 2008;337:a337
Lack of dissent in opt-in mechanisms does not necessarily support a move to opt-out
| The first 150 words of the full text of this article appear below. |
In the linked study, Johnsson and colleagues report levels of dissent in Swedish patients who are asked about storage and future research use of samples collected during health care.1 Only 0.14% of patients dissented to either storage or use of their samples, and 0.063% confirmed their decision by completing a dissent form.
The authors conclude that their survey provides evidence of high levels of trust in the Swedish system, and although this might not translate to other countries or contexts, it may support a move to opt-out systems of regulatory governance. Although the study concerns samples rather than data derived from them, the research value of samples lies in the generalisable data that they can generate, so questions about control of information and access to it are crucial. The suggestion that lack of dissent in an explicit consent system (opt-in) may support a move to presumed consent (opt-out) requires close
Graeme Laurie, professor of medical jurisprudence
1 School of Law, University of Edinburgh, Edinburgh EH8 9YL
Graeme.Laurie@ed.ac.uk
Read all Rapid Responses